COVID-19

Foothold Technology Launches New Solution to Coordinate Care and Track Outcomes for Social Care Networks

NEW YORK--(BUSINESS WIRE)--Foothold Technology, a leading Behavioral Health and Human Services software provider backed by ASG, unveiled a groundbreaking ecosystem…

2 years ago

Legacy ER & Urgent Care Announces Rapid Testing and Treatment for COVID-19, Flu and RSV Amidst Holiday Season Surge

PLANO, TX / ACCESSWIRE / December 21, 2023 / As families gather for the holiday season, Legacy ER & Urgent…

2 years ago

Pharma-Bio Serv Announces Special Dividend

DORADO, PUERTO RICO / ACCESSWIRE / December 21, 2023 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a…

2 years ago

SomaLogic Issues Letter to Stockholders Reiterating Recommendation for Value Maximizing Merger with Standard BioTools

Combination Builds Scale and Accelerates Path to Profitability, Unlocking Significant Potential Value for SomaLogic Stockholders Madryn’s Concerns are Not Based…

2 years ago

Moderna to Present at the 42nd Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, MA / ACCESSWIRE / December 20, 2023 / Moderna, Inc. (Nasdaq:MRNA), today announced that Jamey Mock, Chief Financial Officer,…

2 years ago

Cosmos Health Enters into Definitive Agreement to Acquire Type-2 Diabetes Treatment DIABIT-IS X

CHICAGO, IL / ACCESSWIRE / December 20, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,…

2 years ago

National Minority Quality Forum Announces Published Results of Baseline Minority and Rural Coronavirus Insights Study in Population Health Management

Study finds that despite past headlines, COVID-19 infection rates are higher amongst people of color.Washington, D.C.--(Newsfile Corp. - December 20,…

2 years ago

Significant Health and Quality of Life Improvements Achieved in Children with Achondroplasia Treated for One Year with TransCon™ CNP (Navepegritide) at 100 µg/kg/week

TransCon CNP is the first investigational product to demonstrate improvements in health-related quality of life and disease impacts in children…

2 years ago

Awakn Life Sciences Enters Global Licensing Agreement For Proprietary Sublingual S-Ketamine Formulation With LTS

Agreement Includes Exclusive Rights for Treatment of Addiction, Anxiety and Eating DisordersAlso Includes Access to Phase 1 Data and Patents…

2 years ago

CureVac Announces Decision of German Federal Patent Court in Broad Patent Litigation with BioNTech SE

Validity of CureVac patent EP 1 857 122 B1 denied by German Federal Patent Court after nullity action filed by…

2 years ago